Alfred Onyango Osoti1, Grace John-Stewart, James Kiarie, Barbra Richardson, John Kinuthia, Daisy Krakowiak, Carey Farquhar. 1. aDepartment of Obstetrics & Gynecology, AIC Kijabe Hospital, Kijabe, Kenya bDepartment of Epidemiology cDepartment of Global Health dDepartment of Medicine, University of Washington, Seattle, Washington, USA eDepartment of Obstetrics & Gynecology, University of Nairobi, Nairobi, Kenya fDepartment of Biostatistics, University of Washington, Seattle, Washington, USA gDepartment of Obstetrics & Gynecology, Kenyatta National Hospital, Nairobi, Kenya hVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Abstract
BACKGROUND:HIV testing male partners of pregnant women may decrease HIV transmission to women and promote uptake of prevention of mother-to-child HIV transmission (PMTCT) interventions. However, it has been difficult to access male partners in antenatal care (ANC) clinics. We hypothesized that home visits to offer HIV testing to partners of women attending ANC would increase partner HIV testing. METHODS:Women attending their first ANC were enrolled, interviewed using smartphone audio-computer-assisted self-interviews and randomized to home visits or written invitations for male partners to come to clinic, if they were married or cohabiting, unaccompanied by partners and had no prior couple HIV counselling and testing (CHCT). Enrolled men were offered CHCT (HIV testing and mutual disclosure). Prevalence of CHCT, male HIV seropositivity, couple serodiscordance and intimate partner violence, reported as physical threat from partner, were compared at 6 weeks. RESULTS: Among 495 women screened, 312 were eligible, and 300 randomized to clinic-based or home-based CHCT. Median age was 22 years (interquartile range 20-26 years), and 87% were monogamous. CHCT was significantly higher in home-visit than in clinic-invitation arm (n = 128, 85% vs. n = 54, 36%; P < 0.001). Home-arm identified more HIV-seropositive men (12.0 vs. 8.0%; P = 0.248) and more HIV-discordant couples (14.7 vs. 4.7%; P = 0.003). There was no difference in intimate partner violence. CONCLUSION: Home visits of pregnant women were safe and resulted in more male partner testing and mutual disclosure of HIV status. This strategy could facilitate prevention of maternal HIV acquisition, improve PMTCT uptake and increase male HIV diagnosis.
RCT Entities:
BACKGROUND:HIV testing male partners of pregnant women may decrease HIV transmission to women and promote uptake of prevention of mother-to-childHIV transmission (PMTCT) interventions. However, it has been difficult to access male partners in antenatal care (ANC) clinics. We hypothesized that home visits to offer HIV testing to partners of women attending ANC would increase partner HIV testing. METHODS:Women attending their first ANC were enrolled, interviewed using smartphone audio-computer-assisted self-interviews and randomized to home visits or written invitations for male partners to come to clinic, if they were married or cohabiting, unaccompanied by partners and had no prior couple HIV counselling and testing (CHCT). Enrolled men were offered CHCT (HIV testing and mutual disclosure). Prevalence of CHCT, male HIV seropositivity, couple serodiscordance and intimate partner violence, reported as physical threat from partner, were compared at 6 weeks. RESULTS: Among 495 women screened, 312 were eligible, and 300 randomized to clinic-based or home-based CHCT. Median age was 22 years (interquartile range 20-26 years), and 87% were monogamous. CHCT was significantly higher in home-visit than in clinic-invitation arm (n = 128, 85% vs. n = 54, 36%; P < 0.001). Home-arm identified more HIV-seropositive men (12.0 vs. 8.0%; P = 0.248) and more HIV-discordant couples (14.7 vs. 4.7%; P = 0.003). There was no difference in intimate partner violence. CONCLUSION: Home visits of pregnant women were safe and resulted in more male partner testing and mutual disclosure of HIV status. This strategy could facilitate prevention of maternal HIV acquisition, improve PMTCT uptake and increase male HIV diagnosis.
Authors: Nelly R Mugo; Renee Heffron; Deborah Donnell; Anna Wald; Edwin O Were; Helen Rees; Connie Celum; James N Kiarie; Craig R Cohen; Kayitesi Kayintekore; Jared M Baeten Journal: AIDS Date: 2011-09-24 Impact factor: 4.177
Authors: Juliet N Sekandi; Hassard Sempeera; Justin List; Micheal Angel Mugerwa; Stephen Asiimwe; Xiaoping Yin; Christopher C Whalen Journal: BMC Public Health Date: 2011-09-26 Impact factor: 3.295
Authors: Nora E Rosenberg; Lauren A Graybill; Austin Wesevich; Nuala McGrath; Carol E Golin; Suzanne Maman; Mercy Tsidya; Limbikani Chimndozi; Irving F Hoffman; Mina C Hosseinipour; William C Miller Journal: AIDS Behav Date: 2018-06
Authors: Janet M Turan; Lynae A Darbes; Pamela L Musoke; Zachary Kwena; Anna Joy Rogers; Abigail M Hatcher; Jami L Anderson; George Owino; Anna Helova; Elly Weke; Patrick Oyaro; Elizabeth A Bukusi Journal: AIDS Patient Care STDS Date: 2018-03 Impact factor: 5.078
Authors: Jennifer Mark; John Kinuthia; Alison C Roxby; Daisy Krakowiak; Alfred Osoti; Barbra A Richardson; Molly Ann Gone; Victor Asila; Saloni Parikh; Carey Farquhar Journal: Sex Transm Dis Date: 2017-09 Impact factor: 2.830